Home | Welcome to Contract Pharma   
Last Updated Tuesday, July 29 2014
Print

BASi, Pinnacle Collaborate on Glucose Monitoring



Published May 2, 2013
BASi has entered a collaboration with Pinnacle Technology for proof-of-concept studies combining BASi’s Culex NxT automated blood sampling system with Pinnacle’s glucose sensor to create a new option for quality data collection for diabetes and other glucose research.
 
“Our approach has two important advantages over traditional methods: automation of blood sampling made possible by our Culex NxT, and accurate monitoring of glucose levels using the Pinnacle glucose sensor with no net removal of blood from the test subjects. This allows researchers to take many glucose readings with no ill effects on the test subjects, resulting in more accurate glucose readings than are possible with manual sampling. The system also enables researchers to conduct pharmacokinetic, metabolism, telemetry or microdialysis studies from one set of test subjects instead of using three or four sets, thus lowering study costs,” said Jacqueline M. Lemke, president and chief executive officer and chief financial officer of BASi.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On